137 related articles for article (PubMed ID: 12943673)
1. Inhibition of glycogen phosphorylase (GP) by CP-91,149 induces growth inhibition correlating with brain GP expression.
Schnier JB; Nishi K; Monks A; Gorin FA; Bradbury EM
Biochem Biophys Res Commun; 2003 Sep; 309(1):126-34. PubMed ID: 12943673
[TBL] [Abstract][Full Text] [Related]
2. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
Andersen B; Westergaard N
Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891
[TBL] [Abstract][Full Text] [Related]
3. Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149.
Lerín C; Montell E; Nolasco T; García-Rocha M; Guinovart JJ; Gómez-Foix AM
Biochem J; 2004 Mar; 378(Pt 3):1073-7. PubMed ID: 14651477
[TBL] [Abstract][Full Text] [Related]
4. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
Kaiser A; Nishi K; Gorin FA; Walsh DA; Bradbury EM; Schnier JB
Arch Biochem Biophys; 2001 Feb; 386(2):179-87. PubMed ID: 11368340
[TBL] [Abstract][Full Text] [Related]
5. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines.
Mazzocca A; Giusti S; Hamilton AD; Sebti SM; Pantaleo P; Carloni V
Mol Pharmacol; 2003 Jan; 63(1):159-66. PubMed ID: 12488548
[TBL] [Abstract][Full Text] [Related]
10. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer.
Schnier JB; Nishi K; Gumerlock PH; Gorin FA; Bradbury EM
BMC Urol; 2005 Mar; 5():6. PubMed ID: 15790394
[TBL] [Abstract][Full Text] [Related]
12. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
Gregus Z; Németi B
Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
[TBL] [Abstract][Full Text] [Related]
13. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.
Medema RH; Klompmaker R; Smits VA; Rijksen G
Oncogene; 1998 Jan; 16(4):431-41. PubMed ID: 9484832
[TBL] [Abstract][Full Text] [Related]
14. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
15. Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase.
Harwood HJ; Petras SF; Hoover DJ; Mankowski DC; Soliman VF; Sugarman ED; Hulin B; Kwon Y; Gibbs EM; Mayne JT; Treadway JL
J Lipid Res; 2005 Mar; 46(3):547-63. PubMed ID: 15604516
[TBL] [Abstract][Full Text] [Related]
16. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glycogen phosphorylation induces changes in cellular proteome and signaling pathways in MIA pancreatic cancer cells.
Ma D; Wang J; Zhao Y; Lee WN; Xiao J; Go VL; Wang Q; Recker RR; Xiao GG
Pancreas; 2012 Apr; 41(3):397-408. PubMed ID: 22158071
[TBL] [Abstract][Full Text] [Related]
19. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
[TBL] [Abstract][Full Text] [Related]
20. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.
Fan Z; Lu Y; Wu X; DeBlasio A; Koff A; Mendelsohn J
J Cell Biol; 1995 Oct; 131(1):235-42. PubMed ID: 7559780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
